Ligand Pharmaceuticals Incorporated share price logo

Ligand Pharmaceuticals Incorporated Share Price

NASDAQ: LGND

Mid Cap

$200.24

-4.57

(-2.23%)

as on

Ligand Pharmaceuticals Incorporated Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $199.74
    $210.32
    downward going graph

    0.25%

    Downside

    5.03%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $93.58
    $227.92
    downward going graph

    53.27%

    Downside

    13.82%

    Upside

    downward going graph

Ligand Pharmaceuticals Incorporated share price movements today

Previous Close
$204.81
Open
$210.00
Volume
378.4K
Day's Low - High
$199.74 - $210.32
52 Week Low - High
$93.58 - $227.92

Ligand Pharmaceuticals Incorporated Historical Returns

1 Month Return
+ 11.52 %
3 Month Return
+ 3.76 %
1 Year Return
+ 89.38 %
3 Year Return
+ 197.86 %
5 Year Return
+ 36.56 %

Ligand Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators

Check Ligand Pharmaceuticals Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.1B

EPS (TTM)

8.6263

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

1.03%

PE Ratio (TTM)

33.47

Industry PE ratio

-4.738881355932204

PEG Ratio

1.5271

EBITDA

81.0M

Revenue (TTM)

268.1M

Profit Margin

46.42%

Return On Equity TTM

13.47%

Ligand Pharmaceuticals Incorporated Stock Valuation

Track how Ligand Pharmaceuticals Incorporated P/E has moved over time to understand its valuation trends.

Ligand Pharmaceuticals Incorporated in the last 5 years

  • Overview

  • Trends

Lowest (9.67x)

December 31, 2023

Industry (-4.74x)

March 23, 2026

Today (33.47x)

March 23, 2026

Highest (29.89x)

March 31, 2021

LowHigh

Today’s Price to Earnings Ratio: 33.47x

Ligand Pharmaceuticals Incorporated vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Ligand Pharmaceuticals Incorporated with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Ligand Pharmaceuticals Incorporated image
Ligand Pharmaceuticals Incorporated
BUY$4.1B36.56%33.4746.42%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Ligand Pharmaceuticals Incorporated Stock including INR - Dollar returns

The Ligand Pharmaceuticals Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Ligand Pharmaceuticals Incorporated investment value today

Current value as on today

₹1,95,070

Returns

₹95,070

(+95.07%)

Returns from Ligand Pharmaceuticals Incorporated Stock

₹85,150 (+85.15%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Ligand Pharmaceuticals Incorporated Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Ligand Pharmaceuticals Incorporated. Average target price of $244.5

Ligand Pharmaceuticals Incorporated Share Price Target

Get share price movements and forecasts by analysts on Ligand Pharmaceuticals Incorporated.

What analysts predicted

18.1%UPSIDE

Target Price

$244.5

Current Price

$200.24

Analyzed by

11 Analysts

Target

$244.50

Ligand Pharmaceuticals Incorporated target price $244.5, a slight upside of 18.1% compared to current price of $200.24. According to 11 analysts rating.

Ligand Pharmaceuticals Incorporated Stock’s Investor Sentiment and Interest

Search interest for Ligand Pharmaceuticals Incorporated Stock has increased by 62% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:62% versus previous 30 day period

Ligand Pharmaceuticals Incorporated Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
32
28
30
41
51
42
45
47
115
59
Gross Profit
29
26
19
56
39
39
40
44
90
85
Operating Income
3
-3
2
-19
3
-9
-36
8
54
20
EBITDA
-3
26
122
-55
3
-29
-40
20
149
66
Interest Expense
0
0
0
1
0
0
0
1
0
1
Depreciation
8
8
8
8
8
8
8
8
8
8
Income Before Tax
-12
17
113
-65
-6
-39
-50
11
141
56
Income Tax Expense
-1
-1
27
-13
0
-8
-7
6
23
11
Net Income
-10
18
86
-51
-7
-31
-42
4
117
44
Net Profit Margin
-31.26%
64.72%
278.07%
-124.99%
-13.84%
-72.62%
-93.64%
10.18%
101.57%
75.06%

Ligand Pharmaceuticals Incorporated Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
108
141
251
120
163
241
196
131
167
268
Gross Profit
103
135
245
108
133
179
143
96
156
261
Operating Income
43
68
163
807
37
103
3
11
-22
47
EBITDA
55
81
238
876
56
142
81
100
40
192
Interest Expense
12
11
48
35
27
19
1
0
3
4
Depreciation
-
11
14
43
27
47
34
37
35
33
Income Before Tax
7
57
173
796
1
72
36
63
2
158
Income Tax Expense
10
44
30
167
-5
-4
41
9
6
34
Net Income
-1
12
143
629
-2
57
-33
52
-4
124
Net Profit Margin
-1.50%
8.90%
57.00%
523.19%
-1.82%
23.66%
-17.00%
39.72%
-2.41%
46.42%

Ligand Pharmaceuticals Incorporated Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
18
86
-51
-7
-31
-42
4
117
44
Operating Cash Flow
7
18
13
36
28
-25
15
13
45
Investing Cash Flow
-10
-3
-54
-46
-38
4
-10
-353
-18
Financing Cash Flow
6
12
9
55
20
-4
14
409
8
Change in Cash
3
27
-31
45
8
-24
19
71
35

Ligand Pharmaceuticals Incorporated Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
12
143
629
-2
57
-33
52
-4
124
Operating Cash Flow
93
194
-29
54
78
137
49
97
49
Investing Cash Flow
-84
-423
466
231
30
163
-11
-143
-377
Financing Cash Flow
-7
328
-485
-310
-137
-275
-59
97
428
Change in Cash
1
99
-47
-24
-28
25
-22
49
102

Global Institutional Holdings in Ligand Pharmaceuticals Incorporated

Funds
Holdings
Ashford Capital Management Inc
1.55%
Loomis, Sayles & Company LP
1.92%
UBS Asset Mgmt Americas Inc
1.89%
Northern Trust Corp
1.42%
Northern Trust Corp
1.33%
See all

Insights on Ligand Pharmaceuticals Incorporated

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, LGND has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, LGND stock has moved up by 89.4%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, LGND has outperformed top 5 stocks with highest market-cap in its industry

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 115.46M → 59.66M (in $), with an average decrease of 48.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 117.27M → 44.78M (in $), with an average decrease of 61.8% per quarter

About Ligand Pharmaceuticals Incorporated

ligand, a pharmaceutical company, is assembling a large and diverse portfolio of current and near-term commercial revenue generating assets to assist the long-term financial growth of the company. we operate this business on a lean cost structure that allows us to maximize cash flow and ultimately deliver a meaningful return for our shareholders.
OrganisationLigand Pharmaceuticals Incorporated
Headquarters555 Heritage Drive, Jupiter, FL, United States, 33458
IndustryHealth Technology
CEOMr. Todd C. Davis Ph.D.
E-voting on sharesClick here to vote

Key Management of Ligand Pharmaceuticals Incorporated

Name

Title

Mr. Richard B. Baxter

Senior VP of Investment Operation

Mr. Todd C. Davis Ph.D.

CEO & Director

Mr. Andrew T. Reardon J.D.

Chief Legal Officer & Secretary

Dr. Vincent D. Antle Ph.D.

Senior Vice President of Technical Operations & QA - Capitsol

Mr. Patrick Lucy

Senior VP & CBO Protein Expression Business

Dr. Karen R. Reeves M.D.

Senior VP of Investments & Head of Clinical Strategy

Mr. Octavio Espinoza

Chief Financial Officer

Mr. Paul J. Hadden

Senior Vice President of Investments & Business Development

Ms. Melanie J. Herman CPA

Executive Director of Investor Relations and FP&A

Dr. Keith Marschke Ph.D.

Senior Vice President of Biology & Scientific Affairs

FAQs

What is Ligand Pharmaceuticals Incorporated share price today?

Ligand Pharmaceuticals Incorporated share price today is $200.24 as on at the close of the market. Ligand Pharmaceuticals Incorporated share today touched a day high of $210.32 and a low of $199.74.

What is the 52 week high and 52 week low for Ligand Pharmaceuticals Incorporated share?

Ligand Pharmaceuticals Incorporated share touched a 52 week high of $227.92 on and a 52 week low of $93.58 on . Ligand Pharmaceuticals Incorporated stock price today i.e. is closed at $200.24,which is 12.14% down from its 52 week high and 113.98% up from its 52 week low.

What is Ligand Pharmaceuticals Incorporated's market capitalisation today?

Ligand Pharmaceuticals Incorporated market capitalisation is $0.00T as on .

How to invest in Ligand Pharmaceuticals Incorporated Stock (LGND) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Ligand Pharmaceuticals Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Ligand Pharmaceuticals Incorporated Shares that will get you 0.0075 shares as per Ligand Pharmaceuticals Incorporated share price of $200.24 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Ligand Pharmaceuticals Incorporated Stock (LGND) from India?

Indian investors can start investing in Ligand Pharmaceuticals Incorporated (LGND) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Ligand Pharmaceuticals Incorporated stock (as per the Rupee-Dollar exchange rate as on ). Based on Ligand Pharmaceuticals Incorporated share’s latest price of $200.24 as on March 24, 2026 at 1:29 am IST, you will get 0.0499 shares of Ligand Pharmaceuticals Incorporated. Learn more about fractional shares .

What are the returns that Ligand Pharmaceuticals Incorporated has given to Indian investors in the last 5 years?

Ligand Pharmaceuticals Incorporated stock has given 36.56% share price returns and 29.13% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?